Financial burdens during the COVID-19 pandemic are related to disrupted healthcare utilization among survivors of adolescent and young adult cancers

Purpose We examined whether financial burdens occurring during the COVID-19 pandemic impacted healthcare utilization among survivors of adolescent and young adult cancers. Methods We surveyed survivors enrolled in a patient navigation program to obtain self-reports of delayed/skipped cancer care or other care, changes to medication obtainment, and changes to medication use since the COVID-19 pandemic began. Reported financial burdens were defined as financial toxicity in the past 4 weeks (COmprehensive Score for financial Toxicity [COST] ≤ median 21) and material hardships ( range = 4–11) since March 2020. Adjusted logistic regression models calculated associations and effect modification by gender. Results Survivors ( n = 341) were mostly female (61.3%) and non-Hispanic White (83.3%). Nearly 20% delayed/skipped cancer care, 35.2% delayed/skipped other care, 19.1% changed medication obtainment, and 12.6% changed medication use. Greater material hardships were associated with delayed/skipped cancer care (odds ratio ( OR ) = 3.13, 95% CI = 1.44–6.81) and other care ( OR = 2.17, 95% CI = 1.18–3.98), and changed medication obtainment ( OR = 2.72, 95% CI = 1.43–5.18) or use ( OR = 4.49, 95% CI = 2.05–9.80). Financial toxicity was associated with delayed/skipped other care ( OR = 2.53, 95% CI = 1.31–4.89) and changed medication obtainment ( OR = 1.96, 95% CI = 1.01–3.83) and medication use ( OR = 3.73, 95% CI = 1.59–8.73). The association of material hardships and any changes in healthcare utilization was greater among female compared to male survivors. Conclusion Financial burdens experienced during the pandemic impeded survivors’ ability to utilize necessary healthcare, with worse impacts among female survivors. Implications for Cancer Survivors Delayed or skipped healthcare may lead to an increased cancer mortality or severity of therapy-related conditions. Providing resources that enable survivors experiencing financial burdens to continue critical cancer and preventive care during the COVID-19 pandemic is a priority.